The global CT market is valued at $4.9 billion U.S. (4.62 billion euros) for 2016, according to a report by Kalorama Information.
The firm attributes growth to the increasing number of clinical applications for CT, an aging population, and more chronic disease.
Kalorama also covers the following recent developments in the CT market:
- A low rate in false-positive findings
- Children receiving fewer CT scans now than a decade ago
- More CT angiography (CTA) exams in the Medicare population
- The development of next-generation CT scanners that reduce potentially harmful radiation while still improving overall image quality
- The growing role of CT for advanced prostate cancer
